What Is Clathrin and What Does It Do?

Clathrin is a protein that acts as the cell’s main packaging system, assembling into cage-like structures on the surface of membranes to wrap up and transport cargo from one part of the cell to another. Its most studied job is pulling material from outside the cell into its interior through a process called clathrin-mediated endocytosis, but research over the past two decades has revealed that clathrin also does things nobody initially expected, from stabilizing the machinery of cell division to being exploited by viruses trying to sneak inside. The protein was first purified and named by Barbara Pearse in 1975, and four decades of work since have made it one of the best-understood molecular machines in cell biology.¹

The Three-Legged Shape That Makes It All Work

Clathrin’s signature feature is its shape. Each clathrin unit is a three-legged structure called a triskelion, formed from three heavy chains and three light chains radiating from a central hub. If you have ever seen the three-armed symbol on the flag of the Isle of Man, that is roughly what a single clathrin molecule looks like. This three-legged design is not just decorative: it allows triskelions to interlock with one another and build extended lattices on the surface of a membrane.²

Those lattices can take several forms. The best known are curved, soccer-ball-shaped cages made of hexagons and pentagons, much like a geodesic dome. But clathrin can also assemble into flat sheets or even tubular structures, depending on what the cell needs at that moment.³ The detailed architecture of these assemblies has been worked out using X-ray crystallography for individual domains and cryo-electron microscopy for whole cages, revealing how the legs of neighboring triskelions weave together and where adaptor proteins latch on.⁴

How Clathrin Pulls Things Into the Cell

The process most people associate with clathrin is called clathrin-mediated endocytosis, and it is one of the primary ways your cells grab material from their surroundings. The basic sequence goes like this: the cell needs to bring in a specific molecule, say a growth factor or a nutrient-carrying receptor. That molecule sits on the outer surface of the cell membrane. Adaptor proteins recognize it, gather at the site, and begin recruiting clathrin triskelions to the inner face of the membrane. As more triskelions arrive and lock together, the flat patch of membrane starts to curve inward, forming what researchers call a coated pit.

Electron microscopy of cell surfaces has shown that adaptor proteins alone do not bend the membrane. The membrane stays flat until clathrin arrives and starts building its lattice, meaning clathrin itself is the engine driving the curvature.⁵ Additional proteins help the process along. Epsin, for instance, senses and promotes membrane curvature by inserting a small structural element into the membrane’s lipid layer; it concentrates strongly at highly curved regions, drawn there by its interaction with a specific membrane lipid.⁶ BAR-domain proteins like endophilin contribute in a related way, with their own membrane-inserting segments positioned right at the level of the lipid headgroups to help generate curvature.⁷

Once the pit has deepened into a nearly complete bubble, the neck connecting it to the cell surface has to be pinched shut. This job falls to dynamin, a ring-shaped enzyme that wraps around the neck. A budding coated pit typically recruits somewhere between 26 and 40 dynamin molecules, which assemble into roughly one to one-and-a-half turns of a collar. Experiments using cells partially depleted of dynamin showed that as few as 26 molecules are enough to sever the neck and release the vesicle into the cell’s interior.⁸

Getting the Coat Off

A clathrin-coated vesicle floating inside the cell is not useful until its coat comes off. The coat is sturdy by design, so the cell needs an active disassembly crew. Two proteins handle this: auxilin, which acts as a recruiter, and Hsc70, a chaperone protein that does the physical work. Auxilin binds to a freshly budded vesicle first and calls in Hsc70, directing it to a specific docking site near the end of the clathrin heavy chain.⁹ That docking site contains a short amino-acid sequence (QLMLT) that Hsc70 grabs onto. Without this sequence, the uncoating reaction barely works.¹⁰

The disassembly is not a single yank. Detailed measurements show that releasing one triskelion from the cage requires three rounds of energy consumption by Hsc70, one round per triskelion leg, essentially. Hsc70 binds, uses energy, locks in a small distortion of the lattice, then repeats. The accumulated strain from multiple Hsc70 molecules working at different vertices eventually pops the cage apart.¹¹ The freed triskelions are then recycled for the next round of coat assembly, and the now-naked vesicle can fuse with its target compartment inside the cell.

What Cargo Travels This Way

Clathrin-coated pits are not specialized for one type of cargo. The same pit can carry multiple different receptors simultaneously. Transferrin receptors (which bring iron into the cell) and LDL receptors (which pull in cholesterol-carrying particles) are classic examples, and both are typically found together within the same clathrin structures at the cell surface.¹² The specificity comes not from clathrin itself but from the adaptor proteins that link cargo to the coat. Different adaptors recognize different signals on the tails of receptors, so the same pit can host several adaptors each gripping different receptors.

Growth factor receptors also use this pathway. The epidermal growth factor receptor (EGFR), for example, accumulates within clathrin-coated pits after being activated by its signal molecule. Pulling EGFR off the surface through endocytosis actually dials down its signaling; when researchers blocked the process by depleting dynamin, EGFR stayed active at the surface for longer, amplifying its downstream effects.¹³ This makes clathrin-mediated endocytosis a built-in off switch for certain growth signals, a detail with obvious relevance to cancer biology.

An interesting wrinkle emerged for EGFR at different signal intensities. At low doses of its activating ligand, EGFR enters almost exclusively through the clathrin pathway and does not get tagged for destruction. At higher ligand doses, a substantial fraction instead enters through a clathrin-independent route tied to lipid rafts, and these receptors do get tagged and degraded.¹⁴ The cell, in other words, uses the route of entry as a way to decide a receptor’s fate.

Clathrin in the Brain

Neurons are among the most demanding users of clathrin. Every time a nerve cell fires, small vesicles packed with neurotransmitter fuse with the membrane at the synapse and release their contents. Those vesicle components then need to be recaptured and reassembled into fresh vesicles for the next round of signaling. Decades of evidence point to clathrin-mediated endocytosis as a central mechanism for this recycling.¹⁵ Proteomic analysis of clathrin-coated vesicles isolated from brain tissue found dozens of known synaptic vesicle proteins inside them, consistent with this recycling function.¹⁶

This neuronal dependence on clathrin creates vulnerability. Mutations in the gene encoding auxilin, the brain-specific cochaperone that initiates clathrin coat removal, have been linked to juvenile-onset parkinsonism. In affected patients, the mutation drastically reduces auxilin levels, and without enough auxilin the clathrin coat lingers on vesicles, jamming up the recycling process.¹⁷ The fibroblasts of those patients show normal endocytosis because non-neuronal cells have a backup cochaperone, but neurons rely on auxilin exclusively, so they bear the brunt of the defect. More broadly, emerging genetic and molecular data from both inherited and sporadic forms of Parkinson’s disease implicate multiple players in clathrin-mediated endocytosis as risk factors for neurodegeneration.¹⁸

A Surprise Role in Cell Division

One of the more unexpected discoveries about clathrin came in 2005, when researchers found that it localizes to the mitotic spindle, the structure that separates chromosomes during cell division. Clathrin crosslinks the bundles of filaments (called kinetochore fibers) that pull chromosomes apart, stabilizing them so chromosomes can line up properly before the cell splits. When clathrin heavy chain was depleted using RNA interference, mitosis slowed down, the fibers became unstable, and chromosomes failed to line up at the center of the cell.¹⁹ Rescue experiments showed that full triskelions could restore normal division but the amino-terminal domain alone could not, confirming that the three-legged architecture is what provides the crosslinking ability.²⁰ This function is unrelated to membrane trafficking and highlights how evolution sometimes repurposes existing molecular hardware for entirely new jobs.

How Viruses Exploit the System

Because clathrin-mediated endocytosis is such an efficient way to bring material into cells, several viruses have evolved to hijack it. Influenza A is the textbook example. The virus attaches to the cell surface, gets gathered into a clathrin-coated pit just as if it were a normal receptor-bound cargo, and rides the vesicle into the cell’s interior, where the acidic environment of the endosome triggers the virus to release its genetic material.²¹

The picture is not perfectly simple, though. Experiments blocking clathrin-mediated endocytosis showed that influenza could still enter and infect cells through alternative routes, even when transferrin uptake (a strictly clathrin-dependent process) was completely shut down.²² So the clathrin pathway is the dominant entry route for influenza, but not the only one. This redundancy is part of why influenza is so difficult to block at the cell-entry stage.

The broader lesson is that the existence of multiple entry pathways, both clathrin-dependent and clathrin-independent, gives pathogens options. Some bacteria and their secreted vesicles take advantage of more than one route simultaneously. Outer membrane vesicles from Helicobacter pylori, the stomach bacterium linked to ulcers, enter host cells through both clathrin-dependent and clathrin-independent mechanisms, and knocking out one pathway does not eliminate uptake.²³

Beyond the Cell Surface

Clathrin does not only operate at the outer membrane of the cell. Inside the cell, it coats vesicles budding from the trans-Golgi network, the compartment where newly made proteins are sorted and shipped to their destinations. The adaptor complex AP-1 handles coat assembly at this internal station, directing traffic from the Golgi toward endosomes and lysosomes, the cell’s recycling and degradation centers.²⁴ The vesicle coat proteins used at the Golgi (COPI and COPII) are structurally distinct from clathrin, but all three share a distant common evolutionary origin, suggesting that a primitive coat mechanism diversified early in the history of complex cells.²⁵

Clathrin-Independent Alternatives

Clathrin-mediated endocytosis handles a huge share of cellular import, but it is not the only option. Cells have several clathrin-independent pathways that transport a diverse range of cargo and operate by different principles, some involving lipid-raft-dependent mechanisms and others using bulk membrane uptake.²⁶ Why would cells bother maintaining alternative routes? Partly because different cargoes have different needs, partly for redundancy, and partly because some cargo is better degraded than recycled. As noted with EGFR above, the route a receptor takes into the cell can determine whether it gets sent back to the surface or gets destroyed. That kind of routing decision would be impossible if every cargo traveled the same way.

Clathrin in Drug Delivery

The pharmaceutical and nanotechnology worlds have taken a strong interest in clathrin-mediated endocytosis as a gateway for delivering drugs and imaging agents into cells. Quantum dots, which are nanoscale particles used in both imaging and therapeutic research, enter cells through the clathrin pathway. Both chemical inhibitors and genetic experiments confirm that blocking clathrin-dependent uptake prevents their entry.²⁷

Researchers have also designed nanoparticles decorated with short molecules called aptamers that bind selectively to cancer cell surface receptors. When these aptamer-decorated particles encounter cancer cells, they are internalized through classical clathrin-dependent receptor-mediated endocytosis, much the same way a natural ligand would be taken up.²⁸ Understanding exactly which endocytic pathway a nanoparticle uses matters because it dictates where the particle ends up inside the cell, whether it reaches the compartment where it can release a drug, or whether it gets shunted to a lysosome and destroyed before doing anything useful. Designing particles to exploit clathrin’s well-characterized route gives engineers a measure of control over intracellular fate that would be much harder to achieve with less understood entry pathways.